Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA, LLC, 80159 [2020-27240]
Download as PDF
<![CDATA[
80159
Federal Register / Vol. 85, No. 239 / Friday, December 11, 2020 / Notices
substance within this State . . . shall
obtain a registration issued by the
division in accordance with rules and
regulations promulgated by it.’’).
New Jersey statute defines
‘‘practitioner’’ as a ‘‘physician.’’ N.J.
Stat. Ann. § 24:21–2 (West, current with
laws through L. 2020, c. 109 and J.R. No.
2). It defines ‘‘physician’’ as ‘‘a
physician authorized by law to practice
medicine in this or any other state.’’ Id.
Here, the weight of the evidence in
the record is that Registrant’s license to
practice medicine is currently
suspended and that her CDS registration
is inactive. In New Jersey, as already
discussed, a ‘‘practitioner’’ must be a
physician authorized by law to practice
medicine. Id. As such, she is not a
‘‘physician’’ or a ‘‘practitioner’’ as New
Jersey statute defines those terms. Id.
Thus, since Registrant lacks authority to
practice medicine in New Jersey and
does not have an active New Jersey CDS
registration, she is not eligible to
dispense controlled substances in that
state. N.J. Stat. Ann. § 24:21–11(c). As
such, based on the overwhelming record
evidence and the law in New Jersey, I
find that Registrant is not authorized to
dispense controlled substances in New
Jersey. 21 U.S.C. 824(a)(3). Accordingly,
I will order that Registrant’s DEA
registration be revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. FN5040136 issued to
Anindita Nandi, M.D. This Order is
effective January 11, 2021.
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 24, 2020,
Sterling Pharma USA, LLC, 1001
Sheldon Drive, Suite 101, Cary, North
Carolina 27513–2079, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Tetrahydrocannabinols ..
Drug
code
7370
Schedule
I
The company plans to manufacture in
bulk drug code 7370
(Tetrahydrocannabinols) exclusively
from hemp extract, for distribution and
sale to its customers. No other activities
for this drug code is authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–27240 Filed 12–10–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Timothy J. Shea,
Acting Administrator.
Drug Enforcement Administration
[FR Doc. 2020–27235 Filed 12–10–20; 8:45 am]
BILLING CODE 4410–09–P
[Docket No. DEA–752]
Drug Enforcement Administration
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey, Inc.
[Docket No. DEA–748]
AGENCY:
DEPARTMENT OF JUSTICE
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Bulk Manufacturer of Controlled
Substances Application: Sterling
Pharma USA, LLC
Sterling Pharma USA, LLC
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
SUMMARY:
VerDate Sep<11>2014
00:32 Dec 11, 2020
Jkt 253001
Johnson Matthey, Inc., has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 9, 2021. Such
persons may also file a written request
SUMMARY:
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 9, 2021. Such
persons may also file a written request
for a hearing on the application on or
before February 9, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
PO 00000
Frm 00170
Fmt 4703
Sfmt 4703
for a hearing on the application on or
before February 9, 2021.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on November 2, 2020,
Johnson Matthey, Inc., 2003 Nolte Drive
West Deptford, New Jersey 08066–1742,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Gamma Hydroxybutyric
Acid.
Marihuana ......................
Tetrahydrocannabinols ..
Dihyromorphine .............
Difenoxin ........................
Amphetamine ................
Methamphetamine .........
Lisdexamfetamine .........
Methylphenidate ............
Nabilone ........................
Norfentanyl ....................
Cocaine .........................
Codeine .........................
Dihydrocodeine ..............
Oxycodone ....................
Hydromorphone .............
Diphenoxylate ................
Ecgonine ........................
Hydrocodone .................
Levorphanol ...................
Meperidine .....................
Methadone .....................
Methadone intermediate
Morphine ........................
Thebaine ........................
Opium tincture ...............
Oxymorphone ................
Noroxymorphone ...........
Alfentanil ........................
Remifentanil ...................
Sufentanil .......................
Tapentadol .....................
Fentanyl .........................
Drug
code
Schedule
2010
I
7360
7370
9145
9168
1100
1105
1205
1724
7379
8366
9041
9050
9120
9143
9150
9170
9180
9193
9220
9230
9250
9254
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. In reference to drug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–27241 Filed 12–10–20; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 85, Number 239 (Friday, December 11, 2020)]
[Notices]
[Page 80159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27240]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-748]
Bulk Manufacturer of Controlled Substances Application: Sterling
Pharma USA, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Sterling Pharma USA, LLC has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before February 9,
2021. Such persons may also file a written request for a hearing on the
application on or before February 9, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 24, 2020, Sterling Pharma USA, LLC, 1001
Sheldon Drive, Suite 101, Cary, North Carolina 27513-2079, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to manufacture in bulk drug code 7370
(Tetrahydrocannabinols) exclusively from hemp extract, for distribution
and sale to its customers. No other activities for this drug code is
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-27240 Filed 12-10-20; 8:45 am]
BILLING CODE 4410-09-P
